CT-996

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameCT-996
Drug Alias NameCT-996RG6652RG-6652RO7795081RO-7795081
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandNetherlands +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCarmot Therapeutics IncCarmot Australia First Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche R&D Center (China) LtdCarmot Therapeutics IncF. Hoffmann-La Roche Ag +[5] 
Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A